CLOV is Delivering High Hopes

During the last session 15M of Clover Health Investments, Corp. (NasdaqGS:CLOV)’s shares were traded. The stock closed at $3.72 per share indicating that it lost -$0.12 or -3.13% during that day which brings the Clover Health Investments, Corp.’s valuation to $2.09B.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.8500. That puts it -87.11% from that peak with a 52-week low of $3.6800, while the S&P 500’s share price change was of 28.79%.

What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen decay in its daily volume. The daily volume was of 15M, while in the last 10 days the average was 11.03M and last three months – 15.1M.

Shrinking short interest

The Clover Health Investments, Corp.’s shares are seeing a decreasing short interest compared to the previous month. As of today, there are 25.94M shares being shorted which translates into 1.17 of a short ratio for CLOV, while in the previous month the shorted shares were 31.94M.

Clover Health Investments, Corp. (NasdaqGS:CLOV)’s financials

With a market cap of 2.09B, Clover Health Investments, Corp. holds a total cash of $442.1M that translates into $1.05 per share, while the total debt is of $28.48M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 139.30%. The current revenue is of $1.16B that is $4.07 per share.

This is a great sign for a bright future.